PacBio unveils gene panel for neurological disease study By Investing.com

Published on 12 Mar 2024 on Investing.com

Pacific Biosciences (NASDAQ:PACB) of California, Inc. (NASDAQ: PACB), known as PacBio, has announced...

Read the rest of the article

Start tracking your investments with Statfolio

PacBio faces downgrade after missing Q1 results and lowering outlook, with JPMorgan noting contin...

Seeking Alpha 22 Apr 2024

Goldman Sachs downgrades PacBio (PACB) stock to Neutral from Buy due to the gene sequencing...

Seeking Alpha 18 Apr 2024

Market forces rained on the parade of Pacific Biosciences of California, Inc. (NASDAQ:PACB) share...

Simply Wall St. via Yahoo Finance 18 Apr 2024

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced preli...

Zacks via Yahoo Finance 17 Apr 2024

Gold Moves Higher; Morgan Stanley Earnings Top Views

Investing.com 16 Apr 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.17%

Investing.com 16 Apr 2024

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from it...

Zacks via Yahoo Finance 3 Apr 2024

In our monthly Rare Stock Picks series, we're highlighting March 2024 investment picks. Click her...

Seeking Alpha 3 Apr 2024

Aadi Bioscience, Inc. ( NASDAQ :AADI) has reported that Executive Chairman Neil Desai sold a tota...

Investing.com 2 Apr 2024

Investing.com 2 Apr 2024